Rezultaty - Di Cosimo, Serena
- Rezultaty 1 - 20 Rezultaty od 43
- Idź do następnej strony
-
1
-
2
-
3
-
4
-
5
-
6
Immune checkpoint inhibitors: a physiology-driven approach to the treatment of coronavirus disease 2019 od Di Cosimo, Serena, Malfettone, Andrea, Pérez-García, José M., Llombart-Cussac, Antonio, Miceli, Rosalba, Curigliano, Giuseppe, Cortés, Javier
Wydane 2020Text -
7
COVID‐19 outbreak in Lombardy: Impact on reducing solid cancer diagnoses in 2020 od Trama, Annalisa, Bernasconi, Alice, Botta, Laura, Di Cosimo, Serena, Miceli, Rosalba, Claps, Melanie, Badenchini, Fabio, Lillini, Roberto, Rubino, Massimiliano, Lasalvia, Paolo
Wydane 2022Text -
8
Nobody dares stopping clinical research, not even COVID-19 od Malfettone, Andrea, Di Cosimo, Serena, Pérez-García, José Manuel, García, Alicia, Sampayo-Cordero, Miguel, Mina, Leonardo, Herrero, Carolina, Llombart-Cussac, Antonio, Cortés, Javier
Wydane 2021Text -
9
Early immune modulation by single-agent trastuzumab as a marker of trastuzumab benefit od Triulzi, Tiziana, Regondi, Viola, De Cecco, Loris, Cappelletti, Maria Rosa, Di Modica, Martina, Paolini, Biagio, Lollini, Pier Luigi, Di Cosimo, Serena, Sfondrini, Lucia, Generali, Daniele, Tagliabue, Elda
Wydane 2018Text -
10
ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer od de Azambuja, Evandro, Trapani, Dario, Loibl, Sibylle, Delaloge, Suzette, Senkus, Elzbieta, Criscitiello, Carmen, Poortmans, Philip, Gnant, Michael, Di Cosimo, Serena, Cortes, Javier, Cardoso, Fatima, Paluch-Shimon, Shani, Curigliano, Giuseppe
Wydane 2020Text -
11
Copy number alterations analysis of primary tumor tissue and circulating tumor cells from patients with early-stage triple negative breast cancer od Silvestri, Marco, Dugo, Matteo, Vismara, Marta, De Cecco, Loris, Lanzoni, Davide, Vingiani, Andrea, Folli, Secondo, De Santis, Maria Carmen, de Braud, Filippo, Pruneri, Giancarlo, Di Cosimo, Serena, Cappelletti, Vera
Wydane 2022Text -
12
Tumor Cellularity and Infiltrating Lymphocytes as a Survival Surrogate in HER2-Positive Breast Cancer od Chic, Nuria, Luen, Stephen J, Nuciforo, Paolo, Salgado, Roberto, Fumagalli, Debora, Hilbers, Florentine, Wang, Yingbo, de Azambuja, Evandro, Láng, István, Di Cosimo, Serena, Saura, Cristina, Huober, Jens, Prat, Aleix, Loi, Sherene
Wydane 2021Text -
13
Clinical Implications of Body Mass Index in Metastatic Breast Cancer Patients Treated With Abemaciclib and Endocrine Therapy od Franzoi, Maria Alice, Eiger, Daniel, Ameye, Lieveke, Ponde, Noam, Caparica, Rafael, De Angelis, Claudia, Brandão, Mariana, Desmedt, Christine, Di Cosimo, Serena, Kotecki, Nuria, Lambertini, Matteo, Awada, Ahmad, Piccart, Martine, de Azambuja, Evandro
Wydane 2020Text -
14
Targeted-Gene Sequencing to Catch Triple Negative Breast Cancer Heterogeneity before and after Neoadjuvant Chemotherapy od Di Cosimo, Serena, Appierto, Valentina, Silvestri, Marco, Pruneri, Giancarlo, Vingiani, Andrea, Perrone, Federica, Busico, Adele, Folli, Secondo, Scaperrotta, Gianfranco, de Braud, Filippo Guglielmo, Bianchi, Giulia Valeria, Cavalieri, Stefano, Daidone, Maria Grazia, Dugo, Matteo
Wydane 2019Text -
15
Effect of body mass index on response to neo-adjuvant therapy in HER2-positive breast cancer: an exploratory analysis of the NeoALTTO trial od Di Cosimo, Serena, Porcu, Luca, Agbor-tarh, Dominique, Cinieri, Saverio, Franzoi, Maria Alice, De Santis, Maria Carmen, Saura, Cristina, Huober, Jens, Fumagalli, Debora, Izquierdo, Miguel, Piccart, Martine, Daidone, Maria Grazia, de Azambuja, Evandro
Wydane 2020Text -
16
Circulating Tumor Cell Clusters Are Frequently Detected in Women with Early-Stage Breast Cancer od Reduzzi, Carolina, Di Cosimo, Serena, Gerratana, Lorenzo, Motta, Rosita, Martinetti, Antonia, Vingiani, Andrea, D’Amico, Paolo, Zhang, Youbin, Vismara, Marta, Depretto, Catherine, Scaperrotta, Gianfranco, Folli, Secondo, Pruneri, Giancarlo, Cristofanilli, Massimo, Daidone, Maria Grazia, Cappelletti, Vera
Wydane 2021Text -
17
Association of T-Cell Receptor Repertoire Use With Response to Combined Trastuzumab-Lapatinib Treatment of HER2-Positive Breast Cancer: Secondary Analysis of the NeoALTTO Randomize... od Powles, Ryan L., Redmond, David, Sotiriou, Christos, Loi, Sherene, Fumagalli, Debora, Nuciforo, Paolo, Harbeck, Nadia, de Azambuja, Evandro, Sarp, Severine, Di Cosimo, Serena, Huober, Jens, Baselga, Jose, Piccart-Gebhart, Martine, Elemento, Olivier, Pusztai, Lajos, Hatzis, Christos
Wydane 2018Text -
18
An RB-1 loss of function gene signature as a tool to predict response to neoadjuvant chemotherapy plus anti-HER2 agents: a substudy of the NeoALTTO trial (BIG 1-06) od Risi, Emanuela, Biagioni, Chiara, Benelli, Matteo, Migliaccio, Ilenia, McCartney, Amelia, Bonechi, Martina, Guarducci, Cristina, Hilbers, Florentine, Di Cosimo, Serena, Huober, Jens, Romagnoli, Dario, Boccalini, Giulia, Vitale, Stefania, Sotiriou, Christos, Biganzoli, Laura, Di Leo, Angelo, Malorni, Luca
Wydane 2019Text -
19
Neoadjuvant Chemotherapy Exerts Selection Pressure Towards Luminal Phenotype Breast Cancer od Galli, Giulia, Bregni, Giacomo, Cavalieri, Stefano, Porcu, Luca, Baili, Paolo, Hade, Amash, Di Salvo, Francesca, Sant, Milena, Agresti, Roberto, Gennaro, Massimiliano, Folli, Secondo, De Santis, Maria C., Paolini, Biagio, Carcangiu, Maria L., de Braud, Filippo, Di Cosimo, Serena
Wydane 2017Text -
20
COVID-19 Vaccination in Fragile Patients: Current Evidence and an Harmonized Transdisease Trial od Agrati, Chiara, Di Cosimo, Serena, Fenoglio, Daniela, Apolone, Giovanni, Ciceri, Fabio, Ciliberto, Gennaro, Baldanti, Fausto, Costantini, Massimo, Giannarelli, Diana, Ippolito, Giuseppe, Locatelli, Franco, Mantovani, Alberto, Morrone, Aldo, Tagliavini, Fabrizio, Uccelli, Antonio, Zinzani, Pier Luigi, Silvestris, Nicola, Rescigno, Maria
Wydane 2021Text